Price
$0.00
Increased by +400.00%
Dollar volume (20D)
1.24 K
ADR%
0.93
Shares float
16.69 M
Shares short
430.10 K [2.58%]
Shares outstanding
18.98 M
Market cap
28.47 K
Beta
1.30
Price/earnings
N/A
20D range
0.00 0.06
50D range
0.00 0.07
200D range
0.00 13.93

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects.

It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis.

The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology.

Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.

  • Quarterly earnings
  • Annual earnings
Reported date EPSChange YoY EstimateSurprise
Nov 9, 23 -0.71
Decreased by -154.00%
-0.97
Increased by +26.68%
Aug 14, 23 -3.78
Decreased by -845.00%
-3.30
Decreased by -14.55%
May 15, 23 -0.23
Increased by +58.93%
-0.16
Decreased by -43.75%
Mar 16, 23 -0.21
Increased by +61.11%
-0.28
Increased by +25.00%
Nov 14, 22 -0.28
Increased by +55.56%
-0.33
Increased by +15.15%
Aug 11, 22 -0.40
Increased by +24.53%
-0.43
Increased by +6.98%
May 12, 22 -0.56
Decreased by -1.82%
-0.58
Increased by +3.45%
Mar 24, 22 -0.54
Increased by +12.90%
-0.61
Increased by +11.48%
  • Quarterly financials
  • Annual financials
Fiscal ending date RevenueChange YoY IncomeChange YoY ProfitChange YoY
Sep 30, 23 0.00
Decreased by N/A%
-12.36 M
Increased by +59.55%
Decreased by N/A%
Decreased by N/A%
Jun 30, 23 0.00
Decreased by N/A%
-21.10 M
Increased by +30.95%
Decreased by N/A%
Decreased by N/A%
Mar 31, 23 0.00
Decreased by N/A%
-25.34 M
Increased by +15.14%
Decreased by N/A%
Decreased by N/A%
Dec 31, 22 0.00
Decreased by N/A%
-23.54 M
Increased by +17.84%
Decreased by N/A%
Decreased by N/A%
Sep 30, 22 0.00
Decreased by N/A%
-30.56 M
Increased by +9.39%
Decreased by N/A%
Decreased by N/A%
Jun 30, 22 0.00
Decreased by N/A%
-30.56 M
Increased by +3.28%
Decreased by N/A%
Decreased by N/A%
Mar 31, 22 0.00
Decreased by N/A%
-29.86 M
Decreased by -5.91%
Decreased by N/A%
Decreased by N/A%
Dec 31, 21 0.00
Decreased by N/A%
-28.65 M
Increased by +1.37%
Decreased by N/A%
Decreased by N/A%
Open dropdown content
Open dropdown content
DAILY
WEEKLY
MONTHLY